Aurora, Colorado
CNS clinical trials in Aurora, CO
54 CNS studies are recruiting participants at sites in Aurora as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Aurora at a glance
- 54 studies are recruiting at a site in Aurora.
- By phase: Phase 1/2 (3), Phase 2 (5), Phase 2/3 (1), Phase 3 (16), Phase 4 (4), No phase (14), Observational (11). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (27), industry (23), government (4).
- By research area: Depression (14), Parkinson's Disease (14), Epilepsy (8), Migraine (8), Multiple Sclerosis (8), ADHD (1), Schizophrenia (1).
- Most recent update to one of these records: November 13, 2026.
Depression studies recruiting in Aurora
Basic details from each study's public record (the 30 most recently updated of 54). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Phase 2
- Ages 18 to 80
- All sexes
- Sponsor
- Reunion Neuroscience Inc
- Study site
- University of Colorado
- Registry record
- NCT07002034 · updated
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Study site
- UCHealth University of Colorado Hospital
- Registry record
- NCT06748222 · updated
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Observational
- From 18 months, up to 11 years
- All sexes
- Sponsor
- State University of New York at Buffalo
- Study site
- Children's Hospital Colorado
- Registry record
- NCT07048574 · updated
Brexanolone Lifting Outcomes Of Moms
- Phase 3
- Ages 15 to 45
- Female participants
- Sponsor
- Lipocine Inc.
- Study site
- Lipocine Investigational Site
- Registry record
- NCT07822321 · updated
Modulating Exercise Dosage to Improve Concussion Recovery
- Phase 1/2
- Ages 13 to 18
- All sexes
- Sponsor
- University of Colorado, Denver
- Study site
- University of Colorado Denver
- Registry record
- NCT05434130 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Aurora, CO on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Aurora
Neocortical Microarchitecture of Executive Function
- No phase
- Ages 45 to 85
- All sexes
- Sponsor
- University of Colorado, Denver
- Study site
- University of Colorado
- Registry record
- NCT06778135 · updated
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Boston Scientific Corporation
- Study site
- University of Colorado
- Registry record
- NCT02071134 · updated
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University of Colorado Anschutz Medical Campus ( Site 0151)
- Registry record
- NCT06623422 · updated
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
- Phase 2
- Ages 50 to 80
- All sexes
- Sponsor
- Yale University
- Study site
- University of Colorado Anschutz
- Registry record
- NCT06996652 · updated
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Phase 3
- Ages 45 to 75
- All sexes
- Sponsor
- BlueRock Therapeutics
- Study site
- University of Colorado Hospital - Neurology Clinic
- Registry record
- NCT06944522 · updated
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Phase 2
- Ages 40 to 80
- All sexes
- Sponsor
- Neuron23 Inc.
- Study site
- University of Colorado - Anschutz Medical Campus
- Registry record
- NCT06680830 · updated
Investigating Basal Ganglia-Cortical Physiology During Sleep and Its Modulation by Adaptive Deep Brain Stimulation in Parkinson Disease
- No phase
- Ages 45 to 75
- All sexes
- Sponsor
- University of Colorado, Denver
- Study site
- University of Colorado
- Registry record
- NCT07808346 · updated
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Phase 2/3
- Ages 40 to 80
- All sexes
- Sponsor
- Biohaven Therapeutics Ltd.
- Registry record
- NCT06976268 · updated
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University of Colorado Anschutz Medical Campus ( Site 0061)
- Registry record
- NCT06312176 · updated
Parkinson's Foundation PD GENEration Genetic Registry
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Parkinson's Foundation
- Study site
- University of Colorado Anschutz
- Registry record
- NCT04994015 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Aurora, CO on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Aurora
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Study site
- TG Therapeutics Investigational Trial Site
- Registry record
- NCT06433752 · updated
Care in Multiple Sclerosis (MS)
- Observational
- Ages 18 to 29
- All sexes
- Sponsor
- NYU Langone Health
- Study site
- University of Colorado Denver
- Registry record
- NCT07011914 · updated
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- Phase 3
- Ages 18 to 55
- All sexes
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Study site
- Rocky Mountain Multiple Sclerosis Center, University of Colorado School of Medicine
- Registry record
- NCT04047628 · updated
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- UC Health Neuroscience Ctr
- Registry record
- NCT07225504 · updated
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Sanofi
- Study site
- Rocky Mountain Regional VA Medical Center- Site Number : 8400121
- Registry record
- NCT07325292 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Aurora, CO on ClinicalTrials.gov.
Epilepsy studies recruiting in Aurora
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Neurona Therapeutics
- Study site
- University of Colorado Anschutz Medical Campus
- Registry record
- NCT05135091 · updated
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
- Phase 1/2
- From 6 months, up to 17 years
- All sexes
- Sponsor
- Encoded Therapeutics
- Study site
- Colorado Children's Hospital
- Registry record
- NCT05419492 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Aurora, CO on ClinicalTrials.gov.
Migraine studies recruiting in Aurora
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Phase 4
- Ages 18 to 70
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- University of Colorado Anschutz Medical Campus
- Registry record
- NCT06972056 · updated
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Paradigm Clinical Research Centers, LLC; Aurora
- Registry record
- NCT07816367 · updated
Headache Education and Awareness vs. Daily Mindfulness Strategies - Understanding Pain
- No phase
- Ages 12 to 17
- All sexes
- Sponsor
- University of Colorado, Denver
- Study site
- Children's Hospital Colorado
- Registry record
- NCT07513662 · updated
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study sites
- Children's Hospital Colorado · Children's Hospital Colorado- lnvestigational Drug Services
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study sites
- Children's Hospital Colorado · Children's Hospital Colorado- Investigational Drug Services
- Registry record
- NCT04743141 · updated
Responding With Evidence and Access for Childhood Headaches
- No phase
- Ages 10 to 17
- All sexes
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study site
- University of Colorado/Children's Hospital Colorado
- Registry record
- NCT05889624 · updated
Puberty, Testosterone, and Brain Development
- Observational
- Ages 12 to 20
- All sexes
- Sponsor
- University of Colorado, Denver
- Study site
- Children's Hospital Colorado
- Registry record
- NCT06670053 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study sites
- Children's Hospital Colorado - Aurora /ID# 231879 · Paradigm Clinical Research - Aurora, CO /ID# 280612
- Registry record
- NCT05125302 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Aurora, CO on ClinicalTrials.gov.
Ask about studies near Aurora
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections